Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Cash from Investing Activities of -$139.0 million for Q1 2026, down 4.51% year-over-year from -$145.6 million in Q1 2025, and up 24.04% quarter-over-quarter from -$183.0 million in Q4 2025.
Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Cash from Investing Activities for 18 consecutive years, with -$139.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 4.51% year-over-year to -$139.0 million; the TTM figure through Mar 2026 stood at -$1.2 billion (up 70.85% YoY), while the FY2025 annual figure was -$818.0 million, up 85.17% from the prior year.
- Cash from Investing Activities rose to -$139.0 million in Q1 2026 per BDX's latest filing, from -$183.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $204.0 million in Q4 2024 and bottomed at -$3.9 billion in Q3 2024.
- Historically, Cash from Investing Activities has averaged -$582.8 million across 5 years, with a median of -$288.0 million in 2024.
- On a YoY basis, Cash from Investing Activities climbed as much as 187.55% in 2024 and fell as far as 2973.72% in 2024.
- Becton Dickinson's Cash from Investing Activities stood at -$291.0 million in 2022, then increased by 19.93% to -$233.0 million in 2023, then jumped by 187.55% to $204.0 million in 2024, then tumbled by 189.71% to -$183.0 million in 2025, then grew by 24.04% to -$139.0 million in 2026.
- Business Quant data shows BDX's Cash from Investing Activities at -$139.0 million in Q1 2026, -$183.0 million in Q4 2025, and -$494.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -82.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -241.00 Mn |
| Jun 30, 2026 | -241.00 Mn |
| Mar 31, 2026 | -139.00 Mn |
| Mar 31, 2026 | -139.00 Mn |
| Dec 31, 2025 | -183.00 Mn |
| Dec 31, 2025 | -183.00 Mn |
| Sep 30, 2025 | -494.00 Mn |
| Sep 30, 2025 | -494.00 Mn |
| Jun 30, 2025 | -395.00 Mn |
| Jun 30, 2025 | -395.00 Mn |
| Mar 31, 2025 | -133.00 Mn |
| Mar 31, 2025 | -133.00 Mn |
| Dec 31, 2024 | 204.00 Mn |
| Dec 31, 2024 | 204.00 Mn |
| Sep 30, 2024 | -3.94 Bn |
| Sep 30, 2024 | -3.94 Bn |
| Jun 30, 2024 | -288.00 Mn |
| Jun 30, 2024 | -288.00 Mn |
| Mar 31, 2024 | -1.06 Bn |
| Mar 31, 2024 | -1.06 Bn |